Drug Repositioning: Current Approaches and Their Implications in the Precision Medicine Era

    January 2018 in “ Expert review of precision medicine and drug development ”
    Alan Talevi
    Studysummary This review discusses the integration of drug repurposing with personalized medicine through off-label prescribing and reports no new results, highlighting the potential for systematic exploration using omics technologies.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on ri.conicet.gov.ar →
    Discuss this study in the Community →